Stem Cells in Cardiovascular Diseases: 30,000-Foot View

by Thomas J. Povsic, Bernard J. Gersh
Published 2021-03-01

Comparative analysis of circulating endothelial progenitor cells in age-related macular degeneration patients using automated rare cell analysis (ARCA) and fluorescence activated c...

by Emil Anthony T Say, Alex Melamud, Denise Ann Esserman, Thomas J Povsic, Sai H Chavala
Published 2013-01-01

CD34+ cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory angina

by Grace L. Johnson, Timothy D. Henry, Thomas J. Povsic, Douglas W. Losordo, Ross F. Garberich, Larissa I. Stanberry, Craig E. Strauss, Jay H. Traverse
Published 2020-10-01

“Protocol for a phase 2, randomized, double-blind, placebo-controlled, safety and efficacy study of dutogliptin in combination with filgrastim in early recovery post-myocardial inf...

by Dirk von Lewinski, Joseph B. Selvanayagam, Richard A. Schatz, Bernd Jilma, Jacek Kubica, Thomas J. Povsic, Darrell Nix, Stephan Henauer, Markus Wallner, on behalf of the REC-DUT-002 study group
Published 2020-08-01

ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design

by Tarun Chakravarty, Raj R. Makkar, Deborah D. Ascheim, Jay H. Traverse, Richard Schatz, Anthony Demaria, Gary S. Francis, Thomas J. Povsic, Rachel R. Smith, Joao A. Lima, Janice M. Pogoda, Linda Marbán, Timothy D. Henry
Published 2017-02-01

Correction: Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review

by Timothy D Henry, Dean J Kereiakes, Joao A C Lima, Bharath Ambale-Venkatesh, Mohammad R Ostovaneh, Deborah Ascheim, Raj R Makkar, Tarun Chakravarty, Glen Kowalchuk, Frank V Aguirre, Thomas J Povsic, Richard Schatz, Jay H Traverse, Janice Pogoda, Rachel D Smith, Linda Marbán, Eduardo Marbán
Published 2021-08-01

Effect of cardiosphere-derived cells on segmental myocardial function after myocardial infarction: ALLSTAR randomised clinical trial

by Timothy D Henry, Dean J Kereiakes, Joao A C Lima, Bharath Ambale-Venkatesh, Mohammad R Ostovaneh, Deborah Ascheim, Raj R Makkar, Tarun Chakravarty, Glen Kowalchuk, Frank V Aguirre, Thomas J Povsic, Richard Schatz, Jay H Traverse, Janice Pogoda, Rachel D Smith, Linda Marbán, Eduardo Marbán
Published 2021-08-01

Cardiopoietic stem cell therapy in ischaemic heart failure: long‐term clinical outcomes

by Jozef Bartunek, Andre Terzic, Beth A. Davison, Atta Behfar, Ricardo Sanz‐Ruiz, Wojciech Wojakowski, Warren Sherman, Guy R. Heyndrickx, Marco Metra, Gerasimos S. Filippatos, Scott A. Waldman, John R. Teerlink, Timothy D. Henry, Bernard J. Gersh, Roger Hajjar, Michal Tendera, Stefanie Senger, Gad Cotter, Thomas J. Povsic, William Wijns, for the CHART Program
Published 2020-12-01

Autologous CD34 Cell Therapy for Refractory Angina: 2-Year Outcomes from the ACT34-CMI Study

by Timothy D. Henry, Gary L. Schaer, Jay H. Traverse, Thomas J. Povsic, Charles Davidson, Joon Sup Lee, Marco A. Costa, Theodore Bass, Farrell Mendelsohn, F. David Fortuin, Carl J. Pepine, Amit N. Patel, Norbert Riedel, Candice Junge, Andrea Hunt, Dean J. Kereiakes, Christopher White, Robert A. Harrington, Richard A. Schatz, Douglas W. Losordo
Published 2016-09-01

Reparative cell therapy for the heart: critical internal appraisal of the field in response to recent controversies

by Thomas J. Povsic, Ricardo Sanz‐Ruiz, Andreu M. Climent, Roberto Bolli, Doris A. Taylor, Bernard J. Gersh, Philippe Menasché, Emerson C. Perin, Giulio Pompilio, Douwe E. Atsma, Lina Badimon, Anthony N. DeMaria, Joshua M. Hare, Timothy D. Henry, Stefan Janssens, Jens Kastrup, Daniele Torella, Jay H. Traverse, James T. Willerson, Francisco Fernández‐Avilés
Published 2021-06-01